Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study.

Duncan P, Ridd MJ, McCahon D, Guthrie B, Cabral C.

Br J Gen Pract. 2020 Feb 10. pii: bjgp20X708197. doi: 10.3399/bjgp20X708197. [Epub ahead of print]

PMID:
32041767
2.

Subclinical thyroid dysfunction symptoms in older adults: cross-sectional study in UK primary care.

McCahon D, Haque MS, Parle J, Hobbs FR, Roberts LM.

Br J Gen Pract. 2020 Jan 13. pii: bjgp20X708065. doi: 10.3399/bjgp20X708065. [Epub ahead of print]

PMID:
31932293
3.

A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study).

Bradbury C, Fletcher K, Sun Y, Heneghan C, Gardiner C, Roalfe A, Hardy P, McCahon D, Heritage G, Shackleford H, Hobbs FR, Fitzmaurice D.

Br J Haematol. 2019 Nov 12. doi: 10.1111/bjh.16275. [Epub ahead of print]

PMID:
31713863
4.

Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care.

Duncan P, Cabral C, McCahon D, Guthrie B, Ridd MJ.

Br J Gen Pract. 2019 Mar;69(680):e190-e198. doi: 10.3399/bjgp19X701321. Epub 2019 Feb 11.

5.

Stability of thyroid function in older adults: the Birmingham Elderly Thyroid Study.

Roberts L, McCahon D, Johnson O, Haque MS, Parle J, Hobbs FR.

Br J Gen Pract. 2018 Oct;68(675):e718-e726. doi: 10.3399/bjgp18X698861. Epub 2018 Aug 28.

6.

An evaluation of a coagulation system (Xprecia Stride) for utilisation in anticoagulation management.

McCahon D, Roalfe A, Fitzmaurice DA.

J Clin Pathol. 2018 Jan;71(1):20-26. doi: 10.1136/jclinpath-2017-204456. Epub 2017 Jun 13.

PMID:
28611189
7.

MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care.

Monahan M, Barton P, Taylor CJ, Roalfe AK, Hobbs FDR; REFER investigators, Cowie M, Davis R, Deeks J, Mant J, McCahon D, McDonagh T, Sutton G, Tait L.

Int J Cardiol. 2017 Aug 15;241:255-261. doi: 10.1016/j.ijcard.2017.02.149. Epub 2017 Mar 2.

8.

Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.

Taylor CJ, Roalfe AK, Iles R, Hobbs FR; REFER investigators, Barton P, Deeks J, McCahon D, Cowie MR, Sutton G, Davis RC, Mant J, McDonagh T, Tait L.

Br J Gen Pract. 2017 Feb;67(655):e94-e102. doi: 10.3399/bjgp16X688393. Epub 2016 Dec 5.

9.

Awareness and attitudes towards external auditory canal exostosis and its preventability in surfers in the UK: cross-sectional study.

Morris S, Martin T, Mccahon D, Bennett S.

J Laryngol Otol. 2016 Jul;130(7):628-34. doi: 10.1017/S0022215116008082. Epub 2016 Jun 6.

PMID:
27263424
10.

Assessing the utility of an online registry for patients monitoring their own warfarin therapy.

McCahon D, Baker JM, Murray ET, Fitzmaurice DA.

J Clin Pathol. 2016 Apr;69(4):331-6. doi: 10.1136/jclinpath-2015-203168. Epub 2015 Oct 30.

PMID:
26519487
11.

Enhancing adherence in trials promoting change in diet and physical activity in individuals with a diagnosis of colorectal adenoma; a systematic review of behavioural intervention approaches.

McCahon D, Daley AJ, Jones J, Haslop R, Shajpal A, Taylor A, Wilson S, Dowswell G.

BMC Cancer. 2015 Jul 7;15:505. doi: 10.1186/s12885-015-1502-8. Review.

12.

The burden of common chronic disease on health-related quality of life in an elderly community-dwelling population in the UK.

Parker L, Moran GM, Roberts LM, Calvert M, McCahon D.

Fam Pract. 2014 Oct;31(5):557-63. doi: 10.1093/fampra/cmu035. Epub 2014 Jul 1.

PMID:
24987022
13.

Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study.

Fitzmaurice DA, McCahon D, Baker J, Murray ET, Jowett S, Sandhar H, Holder RL, Hobbs FD.

Fam Pract. 2014 Jun;31(3):298-302. doi: 10.1093/fampra/cmu011. Epub 2014 Apr 12.

PMID:
24728774
14.

A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.

Roberts LM, McCahon D, Holder R, Wilson S, Hobbs FD.

BMC Gastroenterol. 2013 Mar 7;13:45. doi: 10.1186/1471-230X-13-45.

15.

Why are GPs treating subclinical hypothyroidism? Case note review and GP survey.

Allport J, McCahon D, Hobbs FD, Roberts LM.

Prim Health Care Res Dev. 2013 Apr;14(2):175-84. doi: 10.1017/S1463423612000230. Epub 2012 Aug 1.

PMID:
23174158
16.

Does self-management of oral anticoagulation therapy improve quality of life and anxiety?

McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA.

Fam Pract. 2011 Apr;28(2):134-40. doi: 10.1093/fampra/cmq089. Epub 2010 Nov 10.

PMID:
21068191
17.

General practitioners' attitudes to assessment of genetic risk of common disorders in routine primary care.

McCahon D, Holder R, Metcalfe A, Clifford S, Gill P, Cole T, Sleightholme HV, Wilson S.

Clin Genet. 2009 Dec;76(6):544-51. doi: 10.1111/j.1399-0004.2009.01245.x. Epub 2009 Oct 8.

PMID:
19817773
18.

Patient self management of oral anticoagulation in routine care in the UK.

McCahon D, Murray ET, Jowett S, Sandhar HS, Holder RL, Hussain S, O'Donoghue B, Fitzmaurice DA.

J Clin Pathol. 2007 Nov;60(11):1263-7. Epub 2007 Jan 26.

19.

Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis.

Jowett S, Bryan S, Murray E, McCahon D, Raftery J, Hobbs FD, Fitzmaurice D.

Br J Haematol. 2006 Sep;134(6):632-9.

PMID:
16938120
20.

Self management of oral anticoagulation: randomised trial.

Fitzmaurice DA, Murray ET, McCahon D, Holder R, Raftery JP, Hussain S, Sandhar H, Hobbs FD.

BMJ. 2005 Nov 5;331(7524):1057. Epub 2005 Oct 10. Erratum in: BMJ. 2005 Dec 3;331(7528):1330.

21.

Point of care testing for INR monitoring: where are we now?

Murray ET, Fitzmaurice DA, McCahon D.

Br J Haematol. 2004 Nov;127(4):373-8. Review.

PMID:
15521913
22.

Training for patients in a randomised controlled trial of self management of warfarin treatment.

Murray E, Fitzmaurice D, McCahon D, Fuller C, Sandhur H.

BMJ. 2004 Feb 21;328(7437):437-8. No abstract available. Erratum in: BMJ. 2004 Mar;328(7439):563.

23.

SMART: self-management of anticoagulation, a randomised trial [ISRCTN19313375].

McCahon D, Fitzmaurice DA, Murray ET, Fuller CJ, Hobbs RF, Allan TF, Raftery JP.

BMC Fam Pract. 2003 Sep 18;4:11. Print 2003 Sep 18.

25.

Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.

McCahon D, Crowther JR, Belsham GJ, Kitson JD, Duchesne M, Have P, Meloen RH, Morgan DO, De Simone F.

J Gen Virol. 1989 Mar;70 ( Pt 3):639-45.

PMID:
2471793
26.

Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.

Xie QC, McCahon D, Crowther JR, Belsham GJ, McCullough KC.

J Gen Virol. 1987 Jun;68 ( Pt 6):1637-47.

PMID:
2438378
27.

Epitopes on foot-and-mouth disease virus particles. I. Topology.

McCullough KC, Crowther JR, Carpenter WC, Brocchi E, Capucci L, De Simone F, Xie Q, McCahon D.

Virology. 1987 Apr;157(2):516-25.

PMID:
2435060
28.

Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants.

Saunders K, King AM, McCahon D, Newman JW, Slade WR, Forss S.

J Virol. 1985 Dec;56(3):921-9.

29.

Multiple sites of recombination within the RNA genome of foot-and-mouth disease virus.

King AM, McCahon D, Saunders K, Newman JW, Slade WR.

Virus Res. 1985 Nov;3(4):373-84.

PMID:
3000107
30.

Isolation and biochemical characterization of intertypic recombinants of foot-and-mouth disease virus.

McCahon D, King AM, Roe DS, Slade WR, Newman JW, Cleary AM.

Virus Res. 1985 Jul;3(1):87-100.

PMID:
2992184
31.

Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus.

Haresnape JM, King AM, McCahon D.

J Gen Virol. 1983 Nov;64 (Pt 11):2357-65.

PMID:
6196439
32.

Four independent antigenic determinants on the capsid polypeptides of aphthovirus.

Haresnape JM, McCahon D.

J Gen Virol. 1983 Nov;64 (Pt 11):2345-55.

PMID:
6196438
33.

Electrofocusing structural and induced proteins of aphthovirus.

King AM, McCahon D, Newman JW, Crowther JR, Carpenter WC.

Curr Top Microbiol Immunol. 1983;104:219-33. Review. No abstract available.

PMID:
6307592
34.

Recombination in RNA.

King AM, McCahon D, Slade WR, Newman JW.

Cell. 1982 Jul;29(3):921-8.

PMID:
6295637
35.

Biochemical evidence of recombination within the unsegmented RNA genome of aphthovirus.

King AM, McCahon D, Slade WR, Newman JW.

J Virol. 1982 Jan;41(1):66-77.

36.

Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK.

King AM, Underwood BO, McCahon D, Newman JW, Brown F.

Nature. 1981 Oct 8;293(5832):479-80. No abstract available.

PMID:
6273731
37.

Temperature-sensitive RNA polymerase mutants of a picornavirus.

Lowe PA, King AM, McCahon D, Brown F, Newman JW.

Proc Natl Acad Sci U S A. 1981 Jul;78(7):4448-52.

38.

Effect of mutation on the virulence in mice of a strain of foot-and-mouth disease virus.

McCahon D, Slade WR, King AM, Saunders K, Pullen L, Lake JR, Priston RA.

J Gen Virol. 1981 Jun;54(Pt 2):263-72.

PMID:
6270249
39.
40.

The genetics of aphthovirus. Brief review.

McCahon D.

Arch Virol. 1981;69(1):1-23. Review. No abstract available.

PMID:
6271095
42.

The potential of recombination for the production of foot-and-mouth disease virus vaccine strains.

McCahon D, King AM, Slade WR, Skinner HH, Haresnape J.

Dev Biol Stand. 1980;46:223-30.

PMID:
6244999
43.

An extended genetic recombination map for foot-and-mouth diseases virus.

McCahon D, Slade WR, Priston RA, Lake JR.

J Gen Virol. 1977 Jun;35(3):555-65.

PMID:
196035
44.

The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2).

McCahon D, Beare AS, Stealey V.

Postgrad Med J. 1976 Jun;52(608):389-94. No abstract available.

45.

Preparation and characterization of live recombinant influenza vaccine.

Stealey VM, McCahon D, Freestone DS.

Dev Biol Stand. 1976;33:191-6.

PMID:
955267
46.

A single radial haemolysis technique for the measurement of influenza antibody.

Russell SM, McCahon D, Beare AS.

J Gen Virol. 1975 Apr;27(1):1-10.

PMID:
806658
47.

Use of recombination in the production of influenza vaccine strains.

McCahon D, Beare AS, Schild GC, Hall TS.

Postgrad Med J. 1973 Mar;49(569):195-9. No abstract available.

48.

Segregation of antigenic and biological characteristics during influenza virus recombination.

McCahon D, Schild GC.

J Gen Virol. 1972 Apr;15(1):73-7. No abstract available.

PMID:
5025752
49.

An investigation of some factors affecting cross-reactivation between influenza A viruses.

McCahon D, Schild GC.

J Gen Virol. 1971 Sep;12(3):207-19. No abstract available.

PMID:
5165851
50.

Guanidine inhibition of poliovirus: a dependence of viral RNA synthesis on the configuration of structural protein.

Cooper PD, Wentworth BB, McCahon D.

Virology. 1970 Mar;40(3):480-93. No abstract available.

PMID:
4314503

Supplemental Content

Loading ...
Support Center